지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록· 키워드
오류제보하기
Background : The efficacy and safety of clopidogrel in preventing ischemic events have been proven in a randomized double blinded trial(clopidogrel versus aspirin in patients at risk of ischemic events study; CAPRIE). There, also, were many studies confirming in vitro anti-aggregating activity of clopidogrel. Our objective is to determine the pharmacological activity and tolerance of clopidogrel in the patients with ischemic stroke. Patients and Methods : 66 patients who experienced atherosclerotic ischemic stroke participated in the study. They were given clopidogrel at a dose of 75㎎daily for 21days. ADP induced platelet aggregation and bleeding time were tested before starting treatment, 7 and 21 days after treatment. Results : In the presence of ADP(5μM) this inhibition ranged between 43.6% and 55.5% in comparison with pretreatment values. This effect was not significantly different from the previous studies. The clinical tolerance was good or fair in 94% of the patients. No serious adverse events were recorded. Conclusion : Clopidogrel exerted inhibition of ADP induced platelet aggregation and bleeding time prolongation. Our results showed clinical efficacy, pharmacological activity and tolerance of clopidogrel in Korean population. Korean Journal of Stroke 1999;1(1):47~51
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Clopidogrel 약물 상호 작용이 심혈관계 질환 예방 효과 및 부작용에 미치는 영향
한국임상약학회지
2005 .01
-
The Influence of Anti-Platelet Resistance on the Development of Cerebral Ischemic Lesion after Carotid Artery Stenting
Yonsei Medical Journal
2013 .01
-
뇌졸중 환자에게 아스피린과 클로피도그렐 내성
대한뇌졸중학회지
2009 .01
-
Clinical, Pharmacokinetic, and Pharmacogenetic Determinants of Clopidogrel Resistance in Korean Patients with Acute Coronary Syndrome
Annals of Laboratory Medicine
2011 .01
-
Influence of the Concomitant Use of Clopidogrel and Proton Pump Inhibitors on Adverse Cardiovascular Events in Korean Patients with Acute Coronary Syndrome
한국임상약학회지
2014 .01
-
허혈뇌졸중 치료 및 예방을 위한 항혈소판제 병용요법
대한뇌졸중학회지
2010 .01
-
Effects of Triflusal and Clopidogrel on the Secondary Prevention of Stroke Based on Cytochrome P450 2C19 Genotyping
대한뇌졸중학회지
2017 .01
-
The Effect of CYP2C19 Genotype on the Platelet Responsiveness to Clopidogrel in Korean Healthy Subjects
대한임상약리학회 학술대회
2007 .01
-
Acute Ischemic Stroke Associated with Essential Thrombocythemia and Suspected Platelet Aggregation in Intracranial Artery
대한뇌졸중학회지
2011 .01
-
Clopidogrel 투여 후 발생한 가역적 무미증 1례
대한뇌졸중학회지
2002 .01
-
허혈성 뇌졸중 환자에서 트리플루잘 투여에 의한 혈소판 응집능 변화
대한뇌졸중학회지
2000 .01
-
Risk Factors and Biomarkers of Ischemic Stroke in Cancer Patients
대한뇌졸중학회지
2014 .01
-
Clopidogrel Response Variability in Unruptured Intracranial Aneurysm Patients Treated with Stent-Assisted Endovascular Coil Embolization : Is Follow-Up Clopidogrel Response Test Necessary?
대한신경외과학회지
2018 .01
-
신속혈소판기능검사를 이용한 허혈성 뇌졸중 환자에서 아스피린 저항성의 빈도와 관련인자 - 예비연구
대한뇌졸중학회지
2006 .01
-
관상동맥 스텐트 삽입술 후 Clopidogrel과 Cilostazol의 비교
한국임상약학회지
2005 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0